Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1927)
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
584
Price
$228.57
Total Value
$133.49K
Shares Held After
42,798
% of Holdings
1.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
400
Price
$226.78
Total Value
$90.71K
Shares Held After
43,382
% of Holdings
0.9%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,432
Price
$225.97
Total Value
$323.59K
Shares Held After
43,782
% of Holdings
3.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
677
Price
$225.20
Total Value
$152.46K
Shares Held After
45,214
% of Holdings
1.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
491
Price
$223.95
Total Value
$109.96K
Shares Held After
45,891
% of Holdings
1.1%
HYPERION DEFI, INC. (HYPD)
Jung Hyunsu — Director
Shares
2,000
Price
$3.81
Total Value
$7.62K
Shares Held After
1,384,676
% of Holdings
0.1%
NEUROCRINE BIOSCIENCES INC (NBIX)
Onyia Jude — Chief Scientific Officer
Shares
11,000
Price
$160.25
Total Value
$1.76M
Shares Held After
25,846
% of Holdings
29.9%
HYPERION DEFI, INC. (HYPD)
Jung Hyunsu — Director
Shares
5,000
Price
$3.66
Total Value
$18.30K
Shares Held After
1,382,676
% of Holdings
0.4%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
1,922
Price
$10.02
Total Value
$19.26K
Shares Held After
1,057,231
% of Holdings
0.2%
Vir Biotechnology, Inc. (VIR)
Sabatini Brent — SVP, Chief Accounting Officer
Shares
379
Price
$9.45
Total Value
$3.58K
Shares Held After
61,902
% of Holdings
0.6%
Vir Biotechnology, Inc. (VIR)
Napolitano Janet — Director
Shares
3,200
Price
$9.45
Total Value
$30.24K
Shares Held After
21,216
% of Holdings
13.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
1,625
Price
$66.21
Total Value
$107.59K
Shares Held After
43,669
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$554.43
Total Value
$221.77K
Shares Held After
40,513
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$552.82
Total Value
$132.68K
Shares Held After
40,913
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
124
Price
$550.82
Total Value
$68.30K
Shares Held After
41,153
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,070
Price
$550.26
Total Value
$588.77K
Shares Held After
41,277
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,166
Price
$549.31
Total Value
$640.50K
Shares Held After
42,347
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,546
Price
$548.21
Total Value
$847.53K
Shares Held After
43,513
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,376
Price
$547.11
Total Value
$752.82K
Shares Held After
45,059
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,213
Price
$546.21
Total Value
$1.21M
Shares Held After
46,435
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,365
Price
$545.04
Total Value
$743.98K
Shares Held After
48,648
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$554.47
Total Value
$221.79K
Shares Held After
18,876
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
280
Price
$552.92
Total Value
$154.82K
Shares Held After
19,276
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
200
Price
$550.81
Total Value
$110.16K
Shares Held After
19,556
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,015
Price
$550.20
Total Value
$558.45K
Shares Held After
19,756
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,185
Price
$549.30
Total Value
$650.92K
Shares Held After
20,771
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,606
Price
$548.26
Total Value
$880.51K
Shares Held After
21,956
% of Holdings
6.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,354
Price
$547.11
Total Value
$740.79K
Shares Held After
23,562
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,520
Price
$546.23
Total Value
$1.38M
Shares Held After
24,916
% of Holdings
9.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,440
Price
$544.96
Total Value
$784.74K
Shares Held After
27,436
% of Holdings
5.0%
Orchestra BioMed Holdings, Inc. (OBIO)
Hochman David P — Director
Shares
5,000
Price
$3.83
Total Value
$19.15K
Shares Held After
1,064,029
% of Holdings
0.5%
Orchestra BioMed Holdings, Inc. (OBIO)
Sherman Darren — Director
Shares
15,000
Price
$3.87
Total Value
$58.05K
Shares Held After
1,184,327
% of Holdings
1.3%
Concentra Group Holdings Parent, Inc. (CON)
ORTENZIO ROBERT A — Director
Shares
130,000
Price
$25.00
Total Value
$3.25M
Shares Held After
763,455
% of Holdings
14.6%
NATIONAL HEALTHCARE CORP (NHC)
Piercey Lisa — Director
Shares
949
Price
$184.26
Total Value
$174.86K
Shares Held After
949
% of Holdings
100.0%
ClearPoint Neuro, Inc. (CLPT)
Richards Timothy T. — Director
Shares
5,415
Price
$12.17
Total Value
$65.90K
Shares Held After
87,198
% of Holdings
5.8%
Syndax Pharmaceuticals Inc (SNDX)
Goldan Keith A. — Chief Financial Officer
Shares
1,177
Price
$18.99
Total Value
$22.35K
Shares Held After
139,252
% of Holdings
0.8%
Syndax Pharmaceuticals Inc (SNDX)
Metzger Michael A — Director
Shares
6,847
Price
$18.99
Total Value
$130.02K
Shares Held After
484,843
% of Holdings
1.4%
MCKESSON CORP (MCK)
Smith LeAnn B — EVP & Chief HR Officer
Shares
1,810
Price
$735.50
Total Value
$1.33M
Shares Held After
4,798
% of Holdings
27.4%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
924
Price
$91.91
Total Value
$84.92K
Shares Held After
2,162,500
% of Holdings
0.0%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
401
Price
$91.08
Total Value
$36.52K
Shares Held After
2,163,424
% of Holdings
0.0%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
775
Price
$89.79
Total Value
$69.59K
Shares Held After
2,163,825
% of Holdings
0.0%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
400
Price
$88.68
Total Value
$35.47K
Shares Held After
2,164,600
% of Holdings
0.0%
INTUITIVE SURGICAL INC (ISRG)
Jeddi Iman — SVP & GM da Vinci Platforms &
Shares
5,625
Price
$420.55
Total Value
$2.37M
Shares Held After
6,463
% of Holdings
46.5%
HEALTHSTREAM INC (HSTM)
REBROVICK LINDA — Director
Shares
2,000
Price
$25.00
Total Value
$50.00K
Shares Held After
54,181
% of Holdings
3.6%
MAIA Biotechnology, Inc. (MAIA)
Smith Stan — Director
Shares
75,000
Price
$1.34
Total Value
$100.20K
Shares Held After
1,519,178
% of Holdings
4.9%
MAIA Biotechnology, Inc. (MAIA)
Vitoc Vlad — Director
Shares
72,700
Price
$1.39
Total Value
$100.89K
Shares Held After
976,121
% of Holdings
7.4%
MAIA Biotechnology, Inc. (MAIA)
Gryaznov Sergei — Chief Scientific Officer
Shares
2,000
Price
$1.34
Total Value
$2.69K
Shares Held After
46,511
% of Holdings
4.3%
MediWound Ltd. (MDWD)
Fox David Morton — Director
Shares
1,797
Price
$13.99
Total Value
$25.15K
Shares Held After
22,283
% of Holdings
8.1%
MediWound Ltd. (MDWD)
Fox David Morton — Director
Shares
10
Price
$14.23
Total Value
$142.30
Shares Held After
20,486
% of Holdings
0.0%
MediWound Ltd. (MDWD)
Fox David Morton — Director
Shares
1,730
Price
$14.22
Total Value
$24.61K
Shares Held After
20,476
% of Holdings
8.4%
Showing 401–450 of 1927 transactions (page 9 of 39)